Aurobindo Pharma Faces USFDA Observation for Telangana API Unit
The story in brief
Aurobindo Pharma received a USFDA observation for its Apitoria Pharma Pvt Ltd API unit in Telangana following an inspection of Unit II from Sept 7 to 15, 2026. The inspection took place at Gaddapotharam in Sangareddy district. Aurobindo Pharma stated the observation is procedural and will respond within the stipulated timeline. The company also received final approval for its first metered-dose inhaler product, set for launch in the US market in upcoming quarters.